# US-guided Sciatic Nerve Block: Evaluation of the Intraneural Ropivacaine Minimal Effective Volume (MEV90)

> **NCT02589041** · NA · COMPLETED · sponsor: **ASST Gaetano Pini-CTO** · enrollment: 45 (actual)

## Conditions studied

- US-guided Sciatic Nerve Block

## Interventions

- **PROCEDURE:** intraneural sciatic nerve injection
- **DRUG:** Ropivacaine 1%

## Key facts

- **NCT ID:** NCT02589041
- **Lead sponsor:** ASST Gaetano Pini-CTO
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-10
- **Final completion:** 2017-04
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2017-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02589041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02589041, "US-guided Sciatic Nerve Block: Evaluation of the Intraneural Ropivacaine Minimal Effective Volume (MEV90)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02589041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*